Pharma Project SA
The score of Pharma Project shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Project's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −11,278 € | ||||
| Equity | −33,296 € | ||||
| Cash | 11,865 € | ||||
| EBITDA | 83,959 € | ||||
| Total assets | 806,013 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 05 Jan 2026
- Year ended 30 Jun 2024filed on 05 Dec 2024
- Year ended 30 Jun 2023filed on 06 Dec 2023
- Year ended 30 Jun 2022filed on 29 Nov 2022
- Year ended 30 Jun 2021filed on 09 Dec 2021
Pharma Project's financial analysis
- Solvency-4.1%sector median: 18.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Project
Pharma Project's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0458.257.001
- VAT number
- BE0458257001
- Peppol
- Registered · 0208:0458257001 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Jun 1996
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 05 Jan 2026
- Activity
- Buying and selling of own real estate (NACE 68110)
Pharma Project (SA) has been based in Wavre since 1996, active in: buying and selling of own real estate. For 2025, it reports a net loss of 11,278 € and equity of −33,296 €; its revenue is not published. Its solvency stands at -4.1%, below the median of its sector (18.4%).
Companies similar to Pharma Project
Companies in the same business, of comparable size and area, outside its group.
- Nelgerthost Manufacture of basic pharmaceutical products Kruisem · balance sheet 806,000 €
- Avonside Rental and operating of own or leased real estate Grez-Doiceau · balance sheet 806,440 €
- New bs Immo Other information service activities Uccle · balance sheet 805,456 €
- De Blekker Computing infrastructure, data processing, hosting and related activities Koksijde · balance sheet 804,963 €
- I. TOMME, huisarts Kruisem · balance sheet 806,062 €
- Dokter Marc VAN Bellinghen Affligem · balance sheet 805,683 €
- DR. Lanckmans Kampenhout · balance sheet 806,823 €
Frequently asked questions about Pharma Project
What is the revenue of Pharma Project?
Pharma Project files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Project?
In Belgium, the VAT number is the company number prefixed with BE: BE0458257001 for Pharma Project, if the company is VAT-registered. Its company number (CBE) is 0458.257.001.
Where is the registered office of Pharma Project?
According to the CBE register, the registered office of Pharma Project is in 1300 Wavre.
What is the equity of Pharma Project?
At the close of the 2025 financial year, the equity of Pharma Project amounts to -33,296 €, a solvency of -4.1% of total assets.
Who manages Pharma Project?
The register lists 2 active mandates at Pharma Project. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Project
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →